

EXO|E D|TOX is an advanced plant-derived exosome serum designed to condition, hydrate and prepare the skin before professional aesthetic treatment while providing continued daily support at home. Powered by EXO|E’s proprietary Consortia Factors α1 technology, it brings extracellular vesicles, peptides, proteins, amino acids and lipid-based delivery components together within one sophisticated biomimetic formulation.
D|TOX is the first homecare phase of the professional EXO|E system. It is used to create a well-hydrated, balanced and resilient skin environment before treatment and can then continue as the morning maintenance step within an advanced skincare routine.
This is next-generation skincare built around biological communication rather than a conventional single active. Its specialist value lies in the complex network of plant-derived secretory factors contained within the complete CF-α1 platform.
D|TOX uses a biomimetic approach inspired by the way biological systems communicate. Instead of focusing on one isolated vitamin, acid or peptide, EXO|E combines a consortium of plant-derived factors intended to work collectively within the skin environment.
The formula is designed around three connected objectives:
This makes D|TOX both a professional-protocol product and a highly specialised daily serum.
Consortia Factors α1, abbreviated to CF-α1, is the proprietary technology platform at the centre of the EXO|E system. It is described as a collection of plant-derived secretory factors incorporating exosomes and other extracellular vesicles alongside peptides, proteins, amino acids and liposomes.
The word “consortia” reflects the breadth of the platform. Its function is based on multiple biologically derived components operating together rather than one headline ingredient acting alone.
CF-α1 includes:
This multi-component architecture gives D|TOX its distinctive position within professional exosome skincare.
Exosomes belong to the wider family of extracellular vesicles: microscopic lipid-enclosed structures involved in biological communication. These vesicles can transport complex collections of proteins, lipids and other signalling material between biological systems.
EXO|E applies this principle through plant-derived secretory factors. The technology is designed to provide a sophisticated signalling environment that supports the skin’s natural balance, readiness and visible quality.
The plant-derived approach gives EXO|E a distinctive identity within regenerative and procedure-focused skincare. It enables extracellular-vesicle technology to be incorporated into a stable topical homecare system designed for use around professional aesthetic programmes.
The CF-α1 platform uses a proprietary process involving:
These plant and fermentation sources contribute to the secretory-factor environment behind the EXO|E range. Through its proprietary manufacturing process, EXO|E combines the resulting extracellular vesicles and biologically derived factors into the CF-α1 system.
This is considerably more complex than adding a standard botanical extract to a serum. The platform is built around collecting and combining secretory components associated with biological communication.
The visible outcome of an aesthetic treatment is influenced by the condition of the skin before the procedure begins. Dry, uncomfortable or poorly supported skin may be less prepared for an intensive treatment programme.
D|TOX is designed to create a better-conditioned starting point by:
This preparation phase gives the EXO|E system a structured beginning rather than limiting advanced skincare to the day of treatment itself.
The EXO|E system is organised into coordinated phases:
This phased structure allows skin preparation, professional application and restoring homecare to operate as one coherent programme.
Although D|TOX has an important pre-treatment role, its use extends beyond the preparation period. EXO|E also positions it as the continuing morning maintenance serum within the homecare routine.
This allows the skin to receive ongoing hydration and CF-α1 technology after the initial professional programme. D|TOX can therefore be used as a specialist daily serum by people interested in plant-derived extracellular-vesicle technology, even when they are not immediately approaching another treatment.
Its morning position also complements the restoring evening role of EXO|E RE|PAIR 30ml.
D|TOX and RE|PAIR are complementary products with different positions within the EXO|E system.
Using them together creates a complete morning-and-evening EXO|E homecare programme built around the same plant-derived secretory-factor technology.
The EXO|E D|TOX + RE|PAIR Exosomes Kit contains one full-size 30ml bottle of each serum for 60ml of combined homecare.
D|TOX may be particularly relevant for people who:
The published EXO|E protocol describes using D|TOX twice daily for seven days before the professional treatment:
Following the structured treatment period, D|TOX can continue as the morning homecare serum:
Where a practitioner has provided a procedure-specific schedule, follow that schedule for application frequency and the timing of other active skincare.
D|TOX was developed to form part of a professionally directed programme. The treating practitioner can position it around procedures according to the condition of the skin, the treatment being performed and the intended recovery schedule.
Its preconditioning role is particularly valuable because it begins supporting hydration and skin quality before the professional phase. RE|PAIR can then take over the dedicated restoring role afterwards.
EXO|E D|TOX is a 30ml plant-derived exosome serum designed for skin preparation, hydration and continued morning maintenance within the professional EXO|E system.
Yes. D|TOX belongs to the CF-α1 platform, which incorporates plant-derived exosomes and other extracellular vesicles alongside peptides, proteins, amino acids and liposomes.
Consortia Factors α1, or CF-α1, is EXO|E’s proprietary collection of plant-derived secretory factors. It is a multi-component technology designed around biological communication and biomimetic skincare.
It helps hydrate, condition and prepare the skin before the professional phase. This establishes a better-supported skin environment and introduces EXO|E technology before treatment.
Yes. D|TOX is specifically designed as an at-home serum. It is used during preparation and can continue as the morning maintenance step.
Yes. Its morning maintenance role allows the serum to be used for continued hydration, conditioning and access to the CF-α1 plant-derived exosome platform.
D|TOX is the preparation and morning maintenance serum. RE|PAIR provides the restoring post-treatment and evening-maintenance phase. The two products are designed to complement one another.
The individual bottle is appropriate when D|TOX is the required phase or when replenishing an existing routine. The paired kit contains both D|TOX and RE|PAIR for a complete 60ml EXO|E homecare system.
The published professional protocol describes twice-daily application for seven days before treatment. Your practitioner may adapt the schedule to the particular procedure and treatment plan.
Each bottle contains 30ml of serum.
Refer to the supplied EXO|E D|TOX bottle and carton for the current complete ingredient declaration, storage conditions and period-after-opening instructions, particularly when checking known allergies or sensitivities.